Freestone Grove Partners LP Insulet Corp Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Insulet Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 1,594 shares of PODD stock, worth $452,185. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,594Holding current value
$452,185% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PODD
# of Institutions
753Shares Held
63.3MCall Options Held
467KPut Options Held
639K-
Vanguard Group Inc Valley Forge, PA8.49MShares$2.41 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.45MShares$2.11 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.72 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.97MShares$844 Million0.03% of portfolio
-
Baillie Gifford & CO2.36MShares$668 Million0.49% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $19.7B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...